|
⚲
|
| Keyboard |
| Edward Hurwitz | |
|---|---|
| Firm | |
| Address | c/o Protego Biopharma, Inc 10945 Vista Sorrento Parkway, Suite 150 San Diego, CA 92130 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Protego Biopharma Inc | 021-565675 | Director | 32.9 M of 130.4 M |
||
| Recode Therapeutics Inc | 021-561915 | Director | 29.4 M of 29.4 M |
||
| Protego Biopharma | 021-418860 | Director | 51.0 M of 51.0 M |
||
| Recode Therapeutics Inc | 021-418416 | Director | 259.8 M of 290.0 M |
||
| Dyne Therapeutics Inc | 021-373216 | Director | 115.7 M of 115.7 M |
||
| Recode Therapeutics Inc | 021-363315 | Director | 27.5 M of 80.0 M |
||
| Protego Biopharma | 021-355671 | Director | 1.0 M of 1.0 M |
||
| Applied Genetic Technologies Corp | 021-187610 | Director | 8.6 M of 37.5 M |
||
| Calistoga Pharmaceuticals Inc | 021-144409 | Director | 25.0 M of 50.0 M |
||
| Avid Radiopharmaceuticals Inc | 021-84597 | Director | 34.5 M of 34.5 M |
||